See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

Presenter: James Hermiller Jr

October 23, 2012

Presentation TCT 2012

Creating an Incentive Structure Using Score Cards, RVU's, and Benchmarks

Presenter: Charles Brown III

October 23, 2012

Presentation TCT 2012

ELM Presentation

Presenter: J. Dawn Abbott

October 23, 2012

Presentation TCT 2012

Vascular Access Choice and Radiation Exposure

Presenter: Sanjit Jolly

October 23, 2012

Presentation TCT 2012

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Presenter: David Kandzari

October 23, 2012

Presentation TCT 2012

The Physician Executive: Do I Need an MBA or Not?

Presenter: Howard Walpole

October 23, 2012

Presentation TCT 2012

Preclinical Review: Experimental Pathways for Evaluation of Drug Transfer, Tissue Pharmacokinetics, and Vascular Effects

Presenter: Elazer Edelman

October 23, 2012

Presentation TCT 2012

TCT-80. Incidence of Periprocedual Myocardial Infarction in Chronic Total Occlusion PCI and Impact on Clinical Outcome

Presenter: Tasuku Hasegawa

October 23, 2012

Presentation TCT 2012

FDA View on Standard of Care for Functional MR

Presenter: Sonna Patel-Raman

October 23, 2012

Presentation TCT 2012

Valve-in-Valve and Valve-in-Ring Experiences

Presenter: Francesco Maisano

October 23, 2012

Advertisement

Slides

TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

Creating an Incentive Structure Using Score Cards, RVU's, and Benchmarks

ELM Presentation

Vascular Access Choice and Radiation Exposure

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

The Physician Executive: Do I Need an MBA or Not?

Preclinical Review: Experimental Pathways for Evaluation of Drug Transfer, Tissue Pharmacokinetics, and Vascular Effects

TCT-80. Incidence of Periprocedual Myocardial Infarction in Chronic Total Occlusion PCI and Impact on Clinical Outcome

FDA View on Standard of Care for Functional MR

Valve-in-Valve and Valve-in-Ring Experiences

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content